Clinical Trials
Applying Precise Science to the Toughest Questions
If you are interested in participating in a clinical trial, please click on the links below to find trial sites near you that are open for public enrollment.
Our Clinical Trials
We are opening new routes for brain health by harnessing the full therapeutic potential of psychedelic medicine. Clinical trials are crucial for providing the scientific evidence needed for regulatory approvals, ultimately creating a path to new, safe and effective treatment options
Clinical Trials
| Trial Name | Disorder | Product | Status | Location | Trial Information |
|---|---|---|---|---|---|
| Emerge: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, 12-week Study (part A) with a 40-week Open-label Extension (part B) Evaluating the Efficacy and Safety of Oral DT120 Compared to Placebo in the Treatment of Adults | Major Depressive Disorder (MDD) | DT1201 | Actively Recruiting | USA (Multiple Sites) | Find Sites |
| Panorama: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, 12-week Study (part A) with a 40-week Open-label Extension (part B) Evaluating the Efficacy and Safety of Oral DT120 Compared to Placebo in the Treatment of Adults | Generalized Anxiety Disorder (GAD) | DT1201 | Actively Recruiting | USA (Multiple Sites); Europe (Multiple Sites) | Find Sites |
| Voyage: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, 12-week Study (part A) with a 40-week Open-label Extension (part B) Evaluating the Efficacy and Safety of Oral DT120 Compared to Placebo in the Treatment of Adults | Generalized Anxiety Disorder (GAD) | DT1201 | Actively Recruiting | USA (Multiple Sites) | Find Sites |
| A Phase 2a Trial of DT402 for Autism Spectrum Disorder | Autism Spectrum Disorder (ASD) | DT4022 | Actively Recruiting | USA | Find Sites |
| MMED008: A Dose-Finding Study of DT120 for the Treatment of Anxiety Symptoms | Generalized Anxiety Disorder (GAD) | DT1201 | Completed | USA (20 Sites) | Not Recruiting |
| MMED007: Safety and Efficacy of Low Dose DT120 for ADHD Proof of Concept Trial | Attention Deficit/ Hyperactivity Disorder (ADHD) | DT1201 | Completed | Maastricht, Netherlands & Basel, Switzerland | Not Recruiting |
- DT120 also known as MM120
- DT402 also known as MM402
Be a part of what’s next
We are working to turn breakthroughs in the lab into breakthroughs in the lives of people who are most in need. By participating in a clinical trial, you may play a crucial role in improving care and developing potential new treatments that may one day change lives, including your own.
Participant Resources
Visit clinicaltrials.gov to find clinical trials near you. This site is a database of privately and publicly funded clinical studies conducted around the world. Here you can find trials that are actively recruiting for different indications as well as the inclusion and exclusion criteria for different trials. You also have certain rights as a participant in a research study or clinical trial. See the Bill of Rights below for a list of these rights as well as links that provide additional information related to participant safety and research ethics.
As a participant in a research study, you have the right:
- To have enough time to decide whether or not to be in the research study and to make that decision without any pressure from the people who are conducting the research.
- To refuse to be in the study at all, and to stop participating at any time after you begin the study.
- To be told what the study is trying to find out, what will happen to you, and what you will be asked to do if you are in the study.
- To be told about the reasonably foreseeable risks of being in the study.
- To be told about the possible benefits of being in the study.
- To be told whether there are any costs associated with being in the study and whether you will be compensated for participating in the study.
- To be told who will have access to information collected about you, and how your confidentiality will be protected.
- To be told whom to contact with questions about the research, about research-related injury, and about your rights as a research subject.
- To be told about the other non-research treatment choices you have, if the study involves treatment or therapy.
- To be told where treatment is available should you have a research-related injury, and who will pay for research-related treatment.
Additional resources regarding the rights of research participants can be found at the following links:
Regulations to Protect Research Volunteers
Declaration of Helsinki
The Belmont Report
Inside Clinical Trials: Testing Medical Products in People
If you or someone you know is experiencing a crisis or is in need of support and you’re in the U.S., you can call the 24/7 National Suicide Prevention Lifeline at 1-800-273-TALK (8255), text HELLO to the 24/7 Crisis Text Line at 741741, or visit the Suicide Prevention Lifeline website.
If you are outside of the U.S., crisis resources and hotlines can be found at findahelpline.com where you can search for resources available in your location.
If you or someone you know is experiencing a medical, mental health, or other emergency, contact 911 or your region’s designated emergency number or proceed to your nearest emergency department.
